BIIB vs FTV Comparison

Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).

Fortive Corp is a diversified industrial technology firm offering essential technologies, software, and services globally across several industries, such as manufacturing, utilities, medical, electronics, etc. It has two reportable segments: Intelligent Operating Solutions and Advanced Healthcare Solutions. Maximum revenue is generated from the Intelligent Operating Solutions segment, which offers professional instruments used in applications like maintenance, repair, measurement, and condition monitoring, connected worker safety, compliance solutions, etc. The products and services in this segment are marketed under various brands, including Fluke, Servicechannel, Gordian, Accruent, Industrial Scientific, and Intelex. Geographically, the firm generates maximum revenue from North America.